Your browser doesn't support javascript.
loading
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway.
van Os, Jim; Pries, Lotta-Katrin; Ten Have, Margreet; de Graaf, Ron; van Dorsselaer, Saskia; Delespaul, Philippe; Bak, Maarten; Kenis, Gunter; Lin, Bochao D; Luykx, Jurjen J; Richards, Alexander L; Akdede, Berna; Binbay, Tolga; Altinyazar, Vesile; Yalinçetin, Berna; Gümüs-Akay, Güvem; Cihan, Burçin; Soygür, Haldun; Ulas, Halis; Cankurtaran, Eylem Sahin; Kaymak, Semra Ulusoy; Mihaljevic, Marina M; Petrovic, Sanja Andric; Mirjanic, Tijana; Bernardo, Miguel; Mezquida, Gisela; Amoretti, Silvia; Bobes, Julio; Saiz, Pilar A; García-Portilla, María Paz; Sanjuan, Julio; Aguilar, Eduardo J; Santos, José Luis; Jiménez-López, Estela; Arrojo, Manuel; Carracedo, Angel; López, Gonzalo; González-Peñas, Javier; Parellada, Mara; Maric, Nadja P; Atbasoglu, Cem; Ucok, Alp; Alptekin, Köksal; Saka, Meram Can; Arango, Celso; O'Donovan, Michael; Rutten, Bart P F; Guloksuz, Sinan.
Afiliación
  • van Os J; Department of Psychiatry, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Pries LK; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Ten Have M; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • de Graaf R; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • van Dorsselaer S; Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.
  • Delespaul P; Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.
  • Bak M; Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.
  • Kenis G; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Lin BD; FACT, Mondriaan Mental Health, Maastricht, The Netherlands.
  • Luykx JJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Richards AL; FACT, Mondriaan Mental Health, Maastricht, The Netherlands.
  • Akdede B; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Binbay T; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Altinyazar V; Department of Psychiatry, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Yalinçetin B; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Gümüs-Akay G; GGNet Mental Health, Apeldoorn, The Netherlands.
  • Cihan B; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Soygür H; Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Ulas H; Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Cankurtaran ES; Department of Psychiatry, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
  • Kaymak SU; Department of Neuroscience, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey.
  • Mihaljevic MM; Department of Physiology, School of Medicine, Ankara University, Ankara, Turkey.
  • Petrovic SA; Brain Research Center, Ankara University, Ankara, Turkey.
  • Mirjanic T; Department of Psychology, Middle East Technical University, Ankara, Turkey.
  • Bernardo M; Turkish Federation of Schizophrenia Associations, Ankara, Turkey.
  • Mezquida G; Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey (Discharged by statutory decree No:701 at 8 July 2018 because of signing 'Peace Petition').
  • Amoretti S; Güven Çayyolu Healthcare Campus, Ankara, Turkey.
  • Bobes J; Atatürk Research and Training Hospital Psychiatry Clinic, Ankara, Turkey.
  • Saiz PA; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • García-Portilla MP; Institute of Mental Health, Belgrade, Serbia.
  • Sanjuan J; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Aguilar EJ; Institute of Mental Health, Belgrade, Serbia.
  • Santos JL; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Jiménez-López E; Institute of Mental Health, Belgrade, Serbia.
  • Arrojo M; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Carracedo A; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • López G; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • González-Peñas J; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Parellada M; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • Maric NP; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Atbasoglu C; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Ucok A; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • Alptekin K; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Saka MC; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Arango C; Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
  • O'Donovan M; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Rutten BPF; Mental Health Services of Principado de Asturias, Oviedo, Spain.
  • Guloksuz S; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Psychol Med ; 52(10): 1910-1922, 2022 07.
Article en En | MEDLINE | ID: mdl-33070791
ABSTRACT

BACKGROUND:

There is evidence that environmental and genetic risk factors for schizophrenia spectrum disorders are transdiagnostic and mediated in part through a generic pathway of affective dysregulation.

METHODS:

We analysed to what degree the impact of schizophrenia polygenic risk (PRS-SZ) and childhood adversity (CA) on psychosis outcomes was contingent on co-presence of affective dysregulation, defined as significant depressive symptoms, in (i) NEMESIS-2 (n = 6646), a representative general population sample, interviewed four times over nine years and (ii) EUGEI (n = 4068) a sample of patients with schizophrenia spectrum disorder, the siblings of these patients and controls.

RESULTS:

The impact of PRS-SZ on psychosis showed significant dependence on co-presence of affective dysregulation in NEMESIS-2 [relative excess risk due to interaction (RERI) 1.01, p = 0.037] and in EUGEI (RERI = 3.39, p = 0.048). This was particularly evident for delusional ideation (NEMESIS-2 RERI = 1.74, p = 0.003; EUGEI RERI = 4.16, p = 0.019) and not for hallucinatory experiences (NEMESIS-2 RERI = 0.65, p = 0.284; EUGEI -0.37, p = 0.547). A similar and stronger pattern of results was evident for CA (RERI delusions and hallucinations NEMESIS-2 3.02, p < 0.001; EUGEI 6.44, p < 0.001; RERI delusional ideation NEMESIS-2 3.79, p < 0.001; EUGEI 5.43, p = 0.001; RERI hallucinatory experiences NEMESIS-2 2.46, p < 0.001; EUGEI 0.54, p = 0.465).

CONCLUSIONS:

The results, and internal replication, suggest that the effects of known genetic and non-genetic risk factors for psychosis are mediated in part through an affective pathway, from which early states of delusional meaning may arise.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Psychol Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos